|
|
|
Amelioration of motor/sensory dysfunction and spasticity in a rat model of acute lumbar spinal cord injury by human neural stem cell transplantation
Sebastiaan van Gorp, Marjolein Leerink, Osamu Kakinohana, Oleksandr Platoshyn, Camila Santucci, Jan Galik, Elbert A Joosten, Marian Hruska-Plochan, Danielle Goldberg, Silvia Marsala, Karl Johe, Joseph D Ciacci, Martin Marsala Stem Cell Research & Therapy 2013, 4:57 (28 May 2013)
Abstract | Full text | PDF
| PubMed
|
Editor’s summary
Human foetal stem cell grafts improve both motor and sensory functions in rats suffering from a spinal cord injury, demonstrating potential for cell replacement therapy in human spinal cord injuries.
|
|
|
|
Standardization of human stem cell pluripotency using bioinformatics
Michael W Nestor, Scott A Noggle Stem Cell Research & Therapy 2013, 4:37 (25 April 2013)
Abstract | Full text | PDF
| PubMed
|
Editor’s summary
Nestor and Noggle review approaches using bioinformatics and gene profiling to standardize pluripotency assays, one of the major hurdles in the development of high-throughput production of human stem cells for regenerative therapies.
|
|
|
|
Large animal models for stem cell therapy
John Harding, R Roberts, Oleg Mirochnitchenko Stem Cell Research & Therapy 2013, 4:23 (28 March 2013)
Abstract | Full text | PDF
| PubMed
|
Editor’s summary
Oleg Mirochnitchenko and colleagues discuss the importance and current status of large animal models in the preclinical validation of stem cell-based regenerative therapies, including their advantages and challenges.
|
|
|
|
Development of fully defined xeno-free culture system for the preparation and propagation of cell therapy-compliant human adipose stem cells
Mimmi Patrikoski, Miia Juntunen, Shayne Boucher, Andrew Campbell, Mohan C Vemuri, Bettina Mannerström, Susanna Miettinen Stem Cell Research & Therapy 2013, 4:27 (7 March 2013)
Abstract | Full text | PDF
| PubMed
|
Editor’s summary
Adipose stem cells cultured in novel xeno-free/serum-free conditions retained their stem cell characteristics, indicating that the culture conditions have potential future use in the development of clinical cell therapies.
|
|
|
|
Return of results in translational iPS cell research: considerations for donor informed consent
Geoffrey P Lomax, Kelly A Shepard Stem Cell Research & Therapy 2013, 4:6 (21 January 2013)
Abstract | Full text | PDF
| PubMed
|
Editor’s summary
Lomax and Shepherd review the CIRM’s recommendations on informing tissue donors in disease-specific induced pluripotent stem (iPS) cell research, including gaining consent to recontact donors in the event of significant new findings.
|
|
|
|
US Food and Drug Administration international collaborations for cellular therapy product regulation
Judith A Arcidiacono, Joan W Blair, Kimberly A Benton Stem Cell Research & Therapy 2012, 3:38 (28 September 2012)
Abstract | Full text | PDF
| PubMed
|
Editor’s summary
Judith Arcidiacono and colleagues from the US Food and Drug Administration (FDA) review efforts towards international regulatory convergence for cellular therapy products.
|
|
|
|
Glia: an emerging target for neurological disease therapy
Akshata A Almad, Nicholas J Maragakis Stem Cell Research & Therapy 2012, 3:37 (28 September 2012)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
Editor’s summary
Almad and Maragakis discuss the role of glial cells in central nervous system diseases and the potential for glial cell replacement in neurological disease therapy.
|
|
|
|
Stem cells and regenerative medicine
Mahendra Rao Stem Cell Research & Therapy 2012, 3:27 (9 July 2012)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
Editor’s summary
Mahendra Rao introduces a new series on clinical applications of stem cells, discussing the progress made in taking stem cells from the bench to the bedside and the challenges remaining.
|
|
|
|
The Aastrom experience
Ronnda L Bartel, Caryn Cramer, Kelly Ledford, Amy Longcore, Christopher Parrish, Theresa Stern, Sharon Watling, Frank Zeigler Stem Cell Research & Therapy 2012, 3:26 (9 July 2012)
Abstract | Full text | PDF
| PubMed
|
Editor’s summary
Ronnda Bartel and colleagues describe their experience manufacturing an autologous differentiated cell product for the treatment of critical limb ischemia.
|
|
|
|
Mesenchymal stem cells for cartilage repair in osteoarthritis
Pawan K Gupta, Anjan K Das, Anoop Chullikana, Anish S Majumdar Stem Cell Research & Therapy 2012, 3:25 (9 July 2012)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
Editor’s summary
The use of bone marrow stromal cells for cartilage repair and their therapeutic potential in osteoarthritis is discussed by Anish Majumdar and colleagues.
|
|
|
|
Stem cell therapy for the spinal cord
Eleanor M Donnelly, Jason Lamanna, Nicholas M Boulis Stem Cell Research & Therapy 2012, 3:24 (9 July 2012)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
Editor’s summary
Nicholas Boulis and colleagues review clinical trials of stem cell transplantation into the spinal cord focusing on motor neuron diseases and spinal cord injury and discuss the optimization of delivery methods.
|